The effect of systemic administration of XLR11 on (a) analgesia, (b) hypothermia, (c) catalepsy and (d) immobility in WT, CB1‐KO, CB2‐KO, and GPR55‐KO mice. *P < .05, as compared to vehicle. #
P < .05, as compared to the baseline before the XLR11 injection. For WT, n = 7; for CB1‐KO, n = 8; for CB2‐KO, n = 6; for GPR55‐KO, n = 8